Chloramphenicol and the neonate--1979 view

Area of Science:

• Neonatal pharmacology
• Pediatric infectious diseases
• Clinical toxicology

Background:

• The administration of chloramphenicol to newborn infants between 1949 and 1958 led to significant mortality.
• This historical tragedy, often overlooked, resulted from inappropriate dosing regimens.
• Chloramphenicol is a valuable antibiotic, but its use in neonates requires careful management due to potential toxicity.

Purpose of the Study:

• To review the accumulated knowledge regarding chloramphenicol use in newborn infants.
• To highlight the risks associated with historical dosing practices.
• To emphasize the importance of current therapeutic drug monitoring for safe antibiotic administration.

Main Methods:

• Review of historical medical literature and case reports concerning chloramphenicol toxicity in neonates.
• Analysis of pharmacokinetic data related to chloramphenicol metabolism in infants.
• Discussion of advancements in analytical methods for determining blood levels of chloramphenicol.

Main Results:

• Inappropriate chloramphenicol doses were widely administered to newborns, leading to severe toxicity and fatalities.
• The "gray baby syndrome" was a direct consequence of excessive chloramphenicol accumulation.
• Development of sensitive assays for chloramphenicol blood levels is crucial for safe therapeutic use.

Conclusions:

• Historical data underscore the critical need for precise chloramphenicol dosing in neonates.
• Modern analytical techniques enable the safe and effective use of chloramphenicol in this vulnerable population.
• Continued vigilance and adherence to therapeutic drug monitoring are essential to prevent adverse events.